(Q37263571)

19 August 2017

Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus (English)

1 reference

19 August 2017

0 references

1 reference

pulmonary tuberculosis

1 reference

0 references

Aylin Babalik

1

1 reference

19 August 2017

Ismail Hakki Ulus

2

1 reference

19 August 2017

Nadi Bakirci

3

1 reference

19 August 2017

Tulin Kuyucu

4

1 reference

19 August 2017

Huseyin Arpag

5

1 reference

19 August 2017

Lale Dagyildizi

6

1 reference

19 August 2017

Esen Capaner

7

1 reference

19 August 2017

language of work or name

English

0 references

publication date

26 August 2013

1 reference

Antimicrobial Agents and Chemotherapy

19 August 2017

1 reference

19 August 2017

57

1 reference

19 August 2017

11

1 reference

19 August 2017

5740-5742

1 reference

Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Pharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIV

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Therapeutic drug monitoring in the treatment of active tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Type 2 diabetes and multidrug-resistant tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Diabetes mellitus is strongly associated with tuberculosis in Indonesia.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Therapeutic drug monitoring in the treatment of tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

The early bactericidal activity of drugs in patients with pulmonary tuberculosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

Incidence of pulmonary tuberculosis among diabetics.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811326

The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23979746

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determination of ethambutol in plasma by high-performance liquid chromatography after pre-column derivatization

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23979746

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23979746

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.01345-13

1 reference

19 August 2017

1 reference

19 August 2017

1 reference